Obesity News

Advertisement
Medindia's Press Release’ section provides the latest press release on Obesity from across the world for the global audience. This page links to 515 Obesity press releases.

Obesity Action Coalition Thanks the Biden Administration for Proposed Expansion of Obesity Medication Coverage

PR Newswire TAMPA, Fla., Nov. 26, 2024 TAMPA, Fla., Nov. 26, 2024 /PRNewswire/ -- This Thanksgiving week, the Obesity Action Coalition (OAC) extends its gratitude to the Biden Administration for proposing a new rule significantly expanding ...

Advertisement

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

PR Newswire REYKJAVIK, Iceland, Nov. 12, 2024 REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower ...

ObesityWeek®? 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults

PR Newswire BEIJING, Nov. 11, 2024 BEIJING, Nov. 11, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the results of the Phase 2b clinical study of GZR18 injection, a bi-weekly (twice ...

Failure to recognize obesity as a chronic, progressive disease has substantial economic implications, new Obesity Canada data finds

Canada NewsWire EDMONTON, AB, Nov. 7, 2024 Obesity has reached significant levels, where nearly one in three Canadians live with the chronic disease Top-line findings emphasize urgent need for Canada-wide public health strategies ...

Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity

PR Newswire HONG KONG, Nov. 7, 2024 HONG KONG, Nov. 7, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces topline results of its Phase I single ascending dose (SAD) study in Australia in subjects with elevated ...

Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

PR Newswire SEOUL, South Korea, Nov. 6, 2024 Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: ...

Los Angeles Bariatric Surgeon, Dr. David Davtyan, Honored as Fellow of the American Society for Metabolic & Bariatric Surgery (FASMBS)

PR Newswire BEVERLY HILLS, Calif., Nov. 4, 2024 Dr. David Davtyan, a renowned bariatric surgeon in Los Angeles, has been awarded the prestigious title of Fellow of the American Society for Metabolic & Bariatric Surgery (FASMBS) in ...

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network

PR Newswire THE HAGUE, Netherlands, Nov. 4, 2024 Affidea introduces the Roczen platform from Reset Health for the management of obesity and type 2 diabetes, offering personalised care, GLP-1 medications, and improved health outcomes for ...

Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024

PR Newswire SAN DIEGO, Nov. 4, 2024  Up to 6.8% Placebo-Adjusted Mean Weight Loss (8.2% from Baseline) After 28 Days of Dosing with Oral Tablet of VK2735  Encouraging Tolerability Through 100 mg Daily Dosing with Oral VK2735; Mild ...

Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024

PR Newswire MONTREAL, Nov. 3, 2024 - Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - - Congruence's insights into the biology and ...

Advertisement
Advertisement

Obesity News »

Why Do We Crave Unhealthy Food? Is the Brain to Blame?

Why Do We Crave Unhealthy Food? Is the Brain to Blame?

Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.

Surge in Adolescent Overweight/Obesity in England

Surge in Adolescent Overweight/Obesity in England

Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.

Weight Loss Drugs Are Changing What We Eat and How We Buy

Weight Loss Drugs Are Changing What We Eat and How We Buy

The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.

Weight Loss Benefits Last, Even After Regaining Some Weight

Weight Loss Benefits Last, Even After Regaining Some Weight

Losing a lot of weight provides long-term health benefits, even if some weight is regained.

Active Childhood, Stronger Lungs: Childhood Obesity Raises COPD Risk!

Active Childhood, Stronger Lungs: Childhood Obesity Raises COPD Risk!

A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.

More Obesity News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement
Advertisement
Advertisement